Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gabriël E, Jacobs"'
Autor:
Marije E. Otto, Kirsten R. Bergmann, Marieke L. deKam, Kasper Recourt, Gabriël E. Jacobs, Michiel J. vanEsdonk
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 12, Iss 10, Pp 1425-1436 (2023)
Abstract In clinical trials, Montgomery‐Åsberg Depression Rating Scale (MADRS) questionnaire data are added up to total scores before analysis, assuming equal contribution of each separate question. Item Response Theory (IRT)‐based analysis avoi
Externí odkaz:
https://doaj.org/article/b368b3900d9748bb820769f968d0f7b2
Autor:
Clemens, Muehlan, Sander, Brooks, Cedric, Vaillant, Michael, Meinel, Gabriël E, Jacobs, Rob G, Zuiker, Jasper, Dingemanse
Publikováno v:
Clinical Pharmacology and Therapeutics, 111(6), 1334-1342. Wiley-Blackwell
Use of hypnotics is often associated with next-morning residual effects and a higher risk of motor vehicle accidents. Measuring next-morning effects on driving performance is therefore advised by regulatory agencies. Here, we examined driving perform
Autor:
Erik T, Te Beek, Xia, Chen, Gabriël E, Jacobs, Kimberly J, Nahon, Marieke L, de Kam, Jaakko, Lappalainen, Alan J, Cross, Joop M A, van Gerven, Justin L, Hay
Publikováno v:
Clinical pharmacology in drug development. 4(2)
Compounds with selectivity for GABAA receptor subtypes may differ significantly from nonselective benzodiazepines in their dopaminergic effects in vivo. To explore the exact role of the GABAA receptor subtypes in the regulation of prolactin secretion
Autor:
Otto, Marije E.1,2 (AUTHOR) motto@chdr.nl, Bergmann, Kirsten R.1 (AUTHOR), de Kam, Marieke L.1 (AUTHOR), Recourt, Kasper1 (AUTHOR), Jacobs, Gabriël E.1,3 (AUTHOR), van Esdonk, Michiel J.1 (AUTHOR)
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. Oct2023, Vol. 12 Issue 10, p1425-1436. 12p.
Driving Performance after Bedtime Administration of Daridorexant, Assessed in a Sensitive Simulator.
Autor:
Muehlan, Clemens, Brooks, Sander, Vaillant, Cedric, Meinel, Michael, Jacobs, Gabriël E., Zuiker, Rob G., Dingemanse, Jasper
Publikováno v:
Clinical Pharmacology & Therapeutics; Jun2022, Vol. 111 Issue 6, p1334-1342, 9p
Autor:
Dijkstra, Francis M, van de Loo, Aurora JAE, Abdulahad, Smedra, Bosma, Else R, Hartog, Mitch, Huls, Hendrikje, Kuijper, Dianne C, de Vries, Esther, Solanki, Bhavna, Singh, Jaskaran, Aluisio, Leah, Zannikos, Peter, Stuurman, Frederik E, Jacobs, Gabriël E, Verster, Joris C
Publikováno v:
Journal of Psychopharmacology; May2022, Vol. 36 Issue 5, p614-625, 12p
Autor:
te Beek, Erik T.1, Chen, Xia1,2, Jacobs, Gabriël E.1,3, Nahon, Kimberly J.1, de Kam, Marieke L.1, Lappalainen, Jaakko4, Cross, Alan J.4, van Gerven, Joop M. A.1, Hay, Justin L.1
Publikováno v:
Clinical Pharmacology in Drug Development. Mar2015, Vol. 4 Issue 2, p149-154. 6p.
Autor:
Brooks, Sander, Jacobs, Gabriël E., de Boer, Peter, Kent, Justine M., Van Nueten, Luc, van Amerongen, Guido, Zuiker, Rob, Kezic, Iva, Luthringer, Remy, van der Ark, Peter, van Gerven, Joop M. A., Drevets, Wayne, van Gerven, Joop Ma
Publikováno v:
Journal of Psychopharmacology; Feb2019, Vol. 33 Issue 2, p202-209, 8p
This book provides a comprehensive overview of the use of PET and SPECT in the classic psychiatric disorders such as depression, bipolar disorder, anxiety disorders, and schizophrenia. In addition, it discusses the application of these functional neu